New method for treating melanoma using a tnfalpha blocking agent

TNF alpha blocking agent for use in the treatment and prevention of melanoma in a subject in whom melanoma cells express MHCI and in whom stroma cells exhibit TNF alpha expression.

Keywords: melanoma, TNFalpha inhibitors, MHC1
Patent Application number: European Procedure (Patents) (EPA) - 12 Mai 2014 - 14 305 687.7
Inventors:
COLACIOS Céline,LEVADE Thierry,ANDRIEU-ABADIE Nathalie,ROCHAIX Philippe,ROCHOTTE Julia,BENOIST Hervé,BERTRAND Florie

Reference:

BIO14057-T1

Business Developper
contact
Aymeric Empereur
Business Developer
Rare disease: No
Second indication: No

You might also be interested in